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Objectives: The aim of this study was to evaluate the
use of intraoperative DynaCT (IODCT) to asses for suc-
cessful aneurysm exclusion during endovascular aneurysm
repair (EVAR).
Methods: Patients with EVAR who underwent IO-
DCT were retrospectively evaluated. IODCT was per-
formed with the 8sDSA protocol using 10s contrast injec-
tion and a 20s image acquisition time on Artis zeego with
syngo DynaCT (Siemens Healthcare, Forchheim, Ger-
many). Findings were compared with post-procedural
multi slice detector CT (MDCT). 2D images and 3D
post-processing reconstructions (Aquarius Workstation,
TeraRecon, San Mateo, United States) were reviewed.
Radiation dose was documented and contrast doses were
compared between the two modalities. Statistical analysis
was performed using a paired T-test. Results are expressed
as mean  standard error of the mean.
Results: On table, completion IODCT was performed
on 12 patients undergoing EVAR (one infrarenal, 2 juxta-
renal, 9 thoracoabdominal) and 5 patients undergoing
treatment for persistent endoleaks (2 type Ia, 3 type III). 12
cases did not show an endoleak on completion IODCT,
and this was confirmed on follow-up MDCT. In 5 cases,
IODCT detected an endoleak at the completion of the
procedure (one type Ia, one type II and 3 type III en-
doleaks). Type I and III endoleaks were immediately
treated and were not detected on follow-up MDCT. The
type II endoleak was not visualized on follow-up MDCT.
No branch occlusions, stent fractures or component sepa-
rations were noted on IODCT, and this correlated with
follow-up MDCT. Mean skin dose was 0.552Gy (
0.0099) for IODCT and dose length product was 2.665
Gy*cm ( 0.200) for MDCT. Mean contrast dose was
40cc for IODCT compared to 105.29cc ( 26.248) for
MDCT (p  0.001).
Conclusions: IODCT is of sufficient quality to serve
as an imaging modality for evaluating aneurysm exclu-
sion in EVAR with lower contrast dose than MDCT. It
could potentially replace the need for follow-up MDCT.
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Objectives: An elevated cardiac troponin value above
the Upper Reference Limit (URL) is associated with an
increased risk of death following vascular surgery. We hy-
pothesized that combining the peak postoperative troponin
level with the preoperative Revised Cardiac Risk Index
(RCRI) score would optimally predict long-term outcomes
following vascular surgery.
Methods: Two hundred and five consecutive patients
underwent vascular surgery between January 2005 and
December 2007 at the Minneapolis Veterans Affairs (VA)
Medical Center and 164 (80%) had routine troponin I
assays drawn following surgery. Survival was determined
from the centralized VA electronic medical records and
long-term mortality was determined at 2.5 years following
the vascular surgery. Patients with a peak troponin that
exceeded the URL were categorized into LOW POS (3X
URL) and HIGH POS (3X URL) and together with the
preoperative RCRI score, used to predict mortality, based
on a log-binomial regression analysis.
Results: Eighty-five (41.5%) patients had an elevated
peak postoperative troponin value and their long-term risk
of death was increased relative to the remaining cohort
(39% vs 6%; p 0.05). Among the HIGH POS group, the
risk of death was nearly 3-fold higher than the LOW POS
group (p  0.05) and more than 7.5-fold higher than the
NEG group (p  0.05). Based on results from the log-
binomial regression analysis, combining the HIGH POS
group with an RCRI score of 3 had a long-term risk of
death that was 8.69 times higher than all remaining patients
(RR  8.69, 95% CI: 1.26-60.16; p  0.029).
Conclusions: Patients with an elevated postoperative
Troponin I value have an increased risk of mortality. When
the peak troponin is 3X the URL, the risk of long-term
mortality is 3-fold higher and when combined with an
RCRI of 3 or more, increases by 9-fold. These data suggest
that an optimal strategy for postoperative risk-stratification
should consider preoperative clinical risk and peak postop-
erative cardiac troponin values.
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